Paper
8 May 2012 Use of Raman microspectroscopy to score the malignancy of breast cancer cells
C. Nieva, M. Marro, R. Sanz-Pamplona, N. Santana-Codina, S. Rao, D. Petrov, A. Sierra
Author Affiliations +
Abstract
It has been described that benign MCF10A breast cancer cell line suffers phenotypic changes toward malignancy when are cultured in sparse conditions. Using Raman spectroscopy with an InVia Raman microscope (Renishaw) with a backscattered configuration, we have studied the metabolic changes of confluent and sparse MCF10A cell cultures. We used Principal Component Analysis and Partial Least Squares Discriminant Analyses to assess the different profiling of the metabolic composition of breast cancer cells. The results indicated that Raman spectroscopy together with multivariate analysis is a useful technique to distinguish metabolic changes in malignant transformation. The identification of new metabolites, implementing the catalogue on the characterization of the different phenotypes associated to cell malignancy using Raman spectroscopy is under study.
© (2012) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
C. Nieva, M. Marro, R. Sanz-Pamplona, N. Santana-Codina, S. Rao, D. Petrov, and A. Sierra "Use of Raman microspectroscopy to score the malignancy of breast cancer cells", Proc. SPIE 8427, Biophotonics: Photonic Solutions for Better Health Care III, 842713 (8 May 2012); https://doi.org/10.1117/12.921356
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Raman spectroscopy

Breast cancer

Principal component analysis

Statistical analysis

Photons

Remote sensing

Biomedical optics

RELATED CONTENT

Blood proteins analysis by Raman spectroscopy method
Proceedings of SPIE (April 28 2016)
Analysis of human hair by Raman microspectroscopy
Proceedings of SPIE (April 18 2017)
Raman spectroscopy of oral bacteria
Proceedings of SPIE (October 08 2003)
DO-SRS and MPF imaging of metabolic activities
Proceedings of SPIE (March 02 2022)

Back to Top